Press Release - Burzynski.

[Guest guest]

Burzynski has had very good luck curing brain cancer using parts of

nontoxic Amino Acids. The government tried to put him out of business

for about 15 years, but he has somehow held on. F.

 

 

 

Tue, 19 Oct 2004 21:42:20 -0000

Subject:Press Release - Burzynski.

 

Press Release Source: Burzynski Research Institute

 

Houston's Dr. Stanislaw R. Burzynski Receives Cross of Merit Award

from the Polish Government for Pioneering Research in Cancer Treatment

Tuesday October 19, 5:07 pm ET

 

HOUSTON--(BUSINESS WIRE)--Oct. 19, 2004--On Oct. 23, 2004, the Polish

American Congress and the Polish community will celebrate the 150th

Anniversary of the founding of the first permanent Polishsettlement

in America at Panna Maria, Texas, December, 1854. A Gala Awards

Banquet will be held at the Marriott Hotel-Sugar Land on Saturday,

Oct. 23 (6:30 p.m. reception, 8:00 p.m. dinner.) This will be the

culmination of a week-long celebration in Houston, including an art

exhibit, symphony concert and educational forum highlighting Polish

contributions to American culture and society.

 

The awards ceremony at the Gala Banquet on Oct. 23 will include a

presentation of the Polish Cross of Merit to Houston's Stanislaw R.

Burzynski, M.D., Ph.D. and his wife Barbara Burzynski, M.D. in

recognition of their pioneering research and contributions to the

treatment of deadly cancers. The Burzynski Research Institute, which

they founded in 1983 in Stafford, Texas (OTCBB:BZYR - News), has

recently received Orphan Drug Designation from the FDA for its primary

cancer medications (A10 and AS2-1) for treating patients with brain

stem gliomas, the deadliest of brain tumors, for which there

is currently no effective long-term therapy. Other Polish-American

Texans will receive awards for their contributions in music, education

and broadcasting.

 

Distinguished guests at the Gala Banquet will include Lech Walesa,

former

President of the Republic of Poland, His Excellency Przemyslaw

Grudzinski,

Ambassador of the Republic of Poland, Honorable Krystyna Biernacik-

Tokarski, Polish Consul General in Los Angeles, Honorable Zbigniew

Wojciechowski, M.D., Honorary Consul of the Republic of Poland in

Houston,

the Most Reverend Bishop John Yanta, Bishop of Amarillo and Marian L.

Kruzel, President of the Polish American Congress-Texas District.

 

Additional information about the Polish American Congress, the 150th

Anniversary Celebration and the distinguished guests attending can be

obtained by calling Marian Kruzel at 281-561-6304 or Zbigniew

Wojciechowski at 281-565-1507.

 

Burzynski Research Institute is a biopharmaceutical company committed

to developing medicines for serious and life threatening diseases from

genomics and naturally occurring compounds. Research and development

efforts are focused on antineoplastons, autoimmune disease and HIV.

 

Forward-looking statements in this release are made pursuant to the

safe harbor provisions of the federal securities laws. BRI cautions

investors not to place undue reliance on the forward-looking

statements contained in this press release. Information contained in

forward-looking statements is based on current expectations and is

subject to change, and future events may differ materially from those

discussed herein due to a number of factors, including,

but not limited to, risks and uncertainties related to BRI's ability

to obtain regulatory approval for Antineoplastons A10 and AS2-1.

Receiving orphan drug designation does not increase the likelihood of

eventual regulatory approval for a product candidate. BRI does not

undertake to update any such forward-looking statements or to publicly

announce developments or events relating to the matters described herein.

-----------------

----------------------

Contact:

 

Burzynski Research Institute, Houston

Mike Goldberg, 713-335-5609

mgoldberg

www.burzynskiresearch.com